Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -122.56% is in line with its 5-year average of -128.48%, near the high end of its 5-year range (-674.61%–-36.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 55.86% above its 12-month average of -277.68%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -122.56%.
RETURN ON INVESTED CAPITAL (ROIC)
-122.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-277.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-173.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-128.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+55.86%
CURRENT VS 3Y AVG
+29.17%
CURRENT VS 5Y AVG
+4.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.27%
median of 791 covered companies
CURRENT VS SECTOR MEDIAN
-247.50%
vs the sector median at left
CalciMedica, Inc.
Market Cap
$4.65M
Return on Invested Capital (ROIC)
-122.56%
TTM Avg
-277.68%
3Y Avg
-173.03%
5Y Avg
-128.48%
Market Cap
$4.69M
Return on Invested Capital (ROIC)
-38.23%
TTM Avg
-122.97%
3Y Avg
-1403.32%
5Y Avg
-860.06%
Market Cap
$4.78M
Return on Invested Capital (ROIC)
-175.26%
TTM Avg
-258.55%
3Y Avg
-208.94%
5Y Avg
-173.09%
Market Cap
$4.62M
Return on Invested Capital (ROIC)
-19.51%
TTM Avg
-11.65%
3Y Avg
-12.10%
5Y Avg
-17.92%
Market Cap
$4.55M
Return on Invested Capital (ROIC)
-246.61%
TTM Avg
-463.24%
3Y Avg
-303.42%
5Y Avg
-359.05%
Market Cap
$4.43M
Return on Invested Capital (ROIC)
-221.32%
TTM Avg
-119.11%
3Y Avg
-77.97%
5Y Avg
-64.48%
Market Cap
$5.01M
Return on Invested Capital (ROIC)
-43.50%
TTM Avg
-54.16%
3Y Avg
-50.91%
5Y Avg
-58.12%
Market Cap
$5.13M
Return on Invested Capital (ROIC)
-126.69%
TTM Avg
-289.57%
3Y Avg
-198.60%
5Y Avg
-147.26%
Market Cap
$5.10M
Return on Invested Capital (ROIC)
-225.12%
TTM Avg
-13.17%
3Y Avg
-9.09%
5Y Avg
-9.09%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CalciMedica, Inc. (CALC) | $4.65M | -122.56% | -277.68% | -173.03% | -128.48% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.69M | -38.23% | -122.97% | -1403.32% | -860.06% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.78M | -175.26% | -258.55% | -208.94% | -173.09% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.62M | -19.51% | -11.65% | -12.10% | -17.92% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | -246.61% | -463.24% | -303.42% | -359.05% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | -221.32% | -119.11% | -77.97% | -64.48% |
| Xenetic Biosciences, Inc. (XBIO)vs › | $5.01M | -43.50% | -54.16% | -50.91% | -58.12% |
| Imunon, Inc. (IMNN)vs › | $5.13M | -126.69% | -289.57% | -198.60% | -147.26% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.10M | -225.12% | -13.17% | -9.09% | -9.09% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.25M | -116.89% | -117.72% | -83.78% | -61.46% |
ROIC
-122.6%
ROE
-385.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -122.56% |
| 2026-03-31 | -674.61% |
| 2025-12-31 | -209.07% |
| 2025-09-30 | -221.76% |
| 2025-06-30 | -160.39% |
| 2025-03-31 | -119.37% |
| 2024-12-31 | -150.24% |
| 2024-09-30 | -179.81% |
| 2024-06-30 | -125.15% |
| 2024-03-31 | -94.11% |
| 2023-12-31 | -466.78% |
| 2023-09-30 | -303.16% |
| 2023-06-30 | -217.72% |
| 2023-03-31 | -146.79% |
| 2022-09-30 | -36.46% |
| 2022-06-30 | -40.04% |
| 2022-03-31 | -42.67% |
| 2021-12-31 | -48.17% |
| 2021-09-30 | -50.48% |
| 2021-06-30 | -44.77% |
| 2021-03-31 | -39.64% |
| 2020-12-31 | -31.47% |
| 2020-09-30 | -34.40% |
| 2020-06-30 | -228.39% |
